{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T20:49:14Z","timestamp":1761252554740,"version":"3.33.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1136\/ard.2008.092429","type":"journal-article","created":{"date-parts":[[2008,8,20]],"date-time":"2008-08-20T02:48:49Z","timestamp":1219200529000},"page":"1125-1130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Deoxyspergualin in relapsing and refractory Wegener's granulomatosis"],"prefix":"10.1016","volume":"68","author":[{"given":"O","family":"Flossmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Baslund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Bruchfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J W","family":"Cohen Tervaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Heinzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R A","family":"Luqmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Tesar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D R W","family":"Jayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2008.092429_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bmj.2.5091.265","article-title":"Giant-cell granuloma of the respiratory tract (Wegener\u2019s granulomatosis)","volume":"34","author":"Walton","year":"1958","journal-title":"BMJ"},{"key":"10.1136\/ard.2008.092429_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM197908023010503","article-title":"Cyclophosphamide therapy of severe systemic necrotizing vasculitis","volume":"301","author":"Fauci","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.092429_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.092429_bib4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","article-title":"Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study","volume":"41","author":"Booth","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1136\/ard.2008.092429_bib5","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener\u2019s granulomatosis: long-term outcome in 155 patients","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092429_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2008.092429_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/anr.1780320108","article-title":"Infectious complications of cyclophosphamide treatment for vasculitis","volume":"32","author":"Bradley","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092429_bib8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.7326\/0003-4819-119-5-199309010-00003","article-title":"Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy","volume":"119","author":"Boumpas","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2008.092429_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7326\/0003-4819-124-5-199603010-00003","article-title":"Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis","volume":"124","author":"Talar-Williams","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2008.092429_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00007890-199002000-00022","article-title":"A novel rescue drug, 15-deoxyspergualin. First clinical trials for recurrent graft rejection in renal recipients","volume":"49","author":"Amemiya","year":"1990","journal-title":"Transplantation"},{"key":"10.1136\/ard.2008.092429_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.ASN.0000048716.42876.14","article-title":"15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy","volume":"14","author":"Birck","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1136\/ard.2008.092429_bib12","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092429_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092429_bib14","first-page":"671","article-title":"Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"Q J Med"},{"key":"10.1136\/ard.2008.092429_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.1780400222","article-title":"Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides","volume":"40","author":"Exley","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"(5 Suppl","key":"10.1136\/ard.2008.092429_bib16","first-page":"MS253","article-title":"The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study","volume":"30","author":"McHorney","year":"1992","journal-title":"Med Care"},{"key":"10.1136\/ard.2008.092429_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1136\/ard.2008.092429_bib18","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/ard.2004.034645","article-title":"An unusual cause of death in Wegener\u2019s granulomatosis","volume":"65","author":"Suresh","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.092429_bib19","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ndt\/gfh763","article-title":"Prolonged treatment of refractory Wegener\u2019s granulomatosis with 15-deoxyspergualin: an open study in seven patients","volume":"20","author":"Schmitt","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1136\/ard.2008.092429_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10157-005-0396-1","article-title":"Deoxyspergualin, an immunosuppressant, in patients suffering from nephropathies with crescent formation: an open-label trial to evaluate safety and efficacy","volume":"10","author":"Imai","year":"2006","journal-title":"Clin Exp Nephrol"},{"key":"10.1136\/ard.2008.092429_bib21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.092429_bib22","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/ard.2006.060301","article-title":"Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide","volume":"66","author":"Stassen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.092429_bib23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","article-title":"Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"Keogh","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092429_bib24","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2008.092429_bib25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener\u2019s granulomatosis","volume":"352","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.092429_bib26","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"de Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.092429_bib27","first-page":"131","article-title":"Possible mechanism in rat with surviving heart allograft after short course of 15-deoxyspergualin treatment","volume":"32","author":"Jiang","year":"1990","journal-title":"J Clin Lab Immunol"},{"key":"10.1136\/ard.2008.092429_bib28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.1411548","article-title":"Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins","volume":"258","author":"Nadler","year":"1992","journal-title":"Science"},{"key":"10.1136\/ard.2008.092429_bib29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.1998.00602.x","article-title":"Deoxyspergualin preferentially inhibits the growth and maturation of anti-CD40-activated surface IgD+ B lymphocytes","volume":"112","author":"Morikawa","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2008.092429_bib30","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.4049\/jimmunol.155.5.2427","article-title":"Deoxyspergualin inhibits kappa light chain expression in 70Z\/3 pre-B cells by blocking lipopolysaccharide-induced NF-kappa B activation","volume":"155","author":"Tepper","year":"1995","journal-title":"J Immunol"},{"key":"10.1136\/ard.2008.092429_bib31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0192-0561(87)90123-8","article-title":"Decrease of mononuclear phagocyte cell functions and prolongation of graft survival in experimental transplantation by (+\/\u2212)-15-deoxyspergualin","volume":"9","author":"Dickneite","year":"1987","journal-title":"Int J Immunopharmacol"},{"key":"10.1136\/ard.2008.092429_bib32","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.4049\/jimmunol.163.4.1936","article-title":"The HSC73 molecular chaperone: involvement in MHC class II antigen presentation","volume":"163","author":"Panjwani","year":"1999","journal-title":"J Immunol"},{"key":"10.1136\/ard.2008.092429_bib33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2249.2006.03231.x","article-title":"In vivo effects of cyclic administration of 15-deoxyspergualin on leucocyte function in patients with Wegener\u2019s granulomatosis","volume":"146","author":"Kalsch","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2008.092429_bib34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9440(10)62951-3","article-title":"The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies","volume":"167","author":"Xiao","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.2008.092429_bib35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7164\/antibiotics.56.725","article-title":"Inhibition of CTP: phosphocholine cytidylyltransferase activity by 15-deoxyspergualin","volume":"56","author":"Kawada","year":"2003","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1136\/ard.2008.092429_bib36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ndt\/gfi070","article-title":"15-Deoxyspergualin and cyclophosphamide, but not mycophenolate mofetil, prolong survival and attenuate renal disease in a murine model of ANCA-associated crescentic nephritis","volume":"21","author":"Birck","year":"2006","journal-title":"Nephrol Dial Transplant"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724217131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724217131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2008.092429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T05:46:34Z","timestamp":1737351994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724217131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0003496724217131"],"URL":"https:\/\/doi.org\/10.1136\/ard.2008.092429","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deoxyspergualin in relapsing and refractory Wegener's granulomatosis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2008.092429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 2009 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}